Nymox Pharmaceutical Corp  

(Public, NASDAQ:NYMX)   Watch this stock  
Find more results for PAUL MCDONALD, ESQ�
-0.03 (-0.92%)
Nov 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.11 - 3.31
52 week 0.33 - 4.37
Open 3.31
Vol / Avg. 131,059.00/274,535.00
Mkt cap 138.54M
P/E     -
Div/yield     -
EPS -0.62
Shares 42.63M
Beta 1.05
Inst. own 3%

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -41697.78% -155.76%
Operating margin -41595.84% -160.19%
EBITD margin - -159.96%
Return on average assets -8795.63% -384.61%
Return on average equity - -
Employees 24 -
CDP Score - -


306-9900 boul. Cavendish
+1-514-3323222 (Phone)
+1-514-3322227 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Nymox Pharmaceutical Corporation, formerly Corporation Pharmaceutique Nymox, is a biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. The Company also has a patent portfolio covering its marketed products, its investigational drug, as well as other therapeutic and diagnostic indications. The Company also has the United States and global patent rights for the use of statin drugs for the treatment and prevention of Alzheimer's disease. The Company's subsidiaries include Nymox Corporation and Serex, Inc. Nymox Corporation conducts research and development, while Serex conducts research and development, and manufacturing for NicAlert and TobacAlert.

Officers and directors

Paul Averback M.D. Chairman of the Board, President, Chief Executive Officer
Age: 64
Bio & Compensation  - Reuters
Erik Danielsen Chief Financial Officer
Age: 52
Bio & Compensation  - Reuters
Jack Gemmell Chief Information Officer, General Counsel, Director
Age: 63
Bio & Compensation  - Reuters
Brian Doyle Senior Manager - Global Sales and Marketing
Age: 60
Bio & Compensation  - Reuters
Roger Guy M.D. Independent Director
Age: 64
Bio & Compensation  - Reuters
Randall Lanham Esq. Independent Director
Age: 51
Bio & Compensation  - Reuters
Paul F. McDonald Independent Director
Age: 89
Bio & Compensation  - Reuters
David Morse Ph.D. Independent Director
Age: 58
Bio & Compensation  - Reuters